Pay in 4 interest-free payments of $3037.50 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Isabel María Burguillos del Valle(ver más sobre el autor)
Así lo reconoce la Agenda 2030 para el Desarrollo Sostenible
it offers support for every step towards emotional autonomy
o un conjunto de relatos con un hilo conductor
Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders Jessica Taft Isabel María Burguillos del Valle(verExamining Glucagon Like Peptide 1 Receptor (GLP 1R) Agonists for Central Nervous System Disorders Glucagon like peptide 1 receptor (GLP 1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have recently received a lot of national attention. Repurposing GLP 1R agonists to treat some central nervous disorders is promising, but comparatively understudied.
US$ 244.50
US$ 279.50
US$ 444.50
US$ 444.50
US$ 94500.00
US$ 344.50